Copyright Reports & Markets. All rights reserved.

Global Finasteride API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Finasteride API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Abrove 99% Purity
    • 1.3.3 99% Purity
    • 1.3.4 Under 99% Purity
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Finasteride API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Research Organization
    • 1.4.4 Others
  • 1.5 Global Finasteride API Market Size & Forecast
    • 1.5.1 Global Finasteride API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Finasteride API Sales Quantity (2020-2031)
    • 1.5.3 Global Finasteride API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 AMRI
    • 2.1.1 AMRI Details
    • 2.1.2 AMRI Major Business
    • 2.1.3 AMRI Finasteride API Product and Services
    • 2.1.4 AMRI Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 AMRI Recent Developments/Updates
  • 2.2 Mylan
    • 2.2.1 Mylan Details
    • 2.2.2 Mylan Major Business
    • 2.2.3 Mylan Finasteride API Product and Services
    • 2.2.4 Mylan Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Mylan Recent Developments/Updates
  • 2.3 Accord Pharmaceuticals
    • 2.3.1 Accord Pharmaceuticals Details
    • 2.3.2 Accord Pharmaceuticals Major Business
    • 2.3.3 Accord Pharmaceuticals Finasteride API Product and Services
    • 2.3.4 Accord Pharmaceuticals Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Accord Pharmaceuticals Recent Developments/Updates
  • 2.4 Sterling Spa
    • 2.4.1 Sterling Spa Details
    • 2.4.2 Sterling Spa Major Business
    • 2.4.3 Sterling Spa Finasteride API Product and Services
    • 2.4.4 Sterling Spa Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sterling Spa Recent Developments/Updates
  • 2.5 DEAFARMA
    • 2.5.1 DEAFARMA Details
    • 2.5.2 DEAFARMA Major Business
    • 2.5.3 DEAFARMA Finasteride API Product and Services
    • 2.5.4 DEAFARMA Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 DEAFARMA Recent Developments/Updates
  • 2.6 Gadea Grupo Farmacéutico, S.L.U.
    • 2.6.1 Gadea Grupo Farmacéutico, S.L.U. Details
    • 2.6.2 Gadea Grupo Farmacéutico, S.L.U. Major Business
    • 2.6.3 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Product and Services
    • 2.6.4 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Gadea Grupo Farmacéutico, S.L.U. Recent Developments/Updates
  • 2.7 Hetero
    • 2.7.1 Hetero Details
    • 2.7.2 Hetero Major Business
    • 2.7.3 Hetero Finasteride API Product and Services
    • 2.7.4 Hetero Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Hetero Recent Developments/Updates
  • 2.8 Dr.Reddys Laboratories
    • 2.8.1 Dr.Reddys Laboratories Details
    • 2.8.2 Dr.Reddys Laboratories Major Business
    • 2.8.3 Dr.Reddys Laboratories Finasteride API Product and Services
    • 2.8.4 Dr.Reddys Laboratories Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Dr.Reddys Laboratories Recent Developments/Updates
  • 2.9 Pharmaffiliates
    • 2.9.1 Pharmaffiliates Details
    • 2.9.2 Pharmaffiliates Major Business
    • 2.9.3 Pharmaffiliates Finasteride API Product and Services
    • 2.9.4 Pharmaffiliates Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Pharmaffiliates Recent Developments/Updates
  • 2.10 Cipla
    • 2.10.1 Cipla Details
    • 2.10.2 Cipla Major Business
    • 2.10.3 Cipla Finasteride API Product and Services
    • 2.10.4 Cipla Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Cipla Recent Developments/Updates
  • 2.11 Henan Topfond
    • 2.11.1 Henan Topfond Details
    • 2.11.2 Henan Topfond Major Business
    • 2.11.3 Henan Topfond Finasteride API Product and Services
    • 2.11.4 Henan Topfond Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Henan Topfond Recent Developments/Updates
  • 2.12 Khonsu International
    • 2.12.1 Khonsu International Details
    • 2.12.2 Khonsu International Major Business
    • 2.12.3 Khonsu International Finasteride API Product and Services
    • 2.12.4 Khonsu International Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Khonsu International Recent Developments/Updates
  • 2.13 Aurobindo Pharma
    • 2.13.1 Aurobindo Pharma Details
    • 2.13.2 Aurobindo Pharma Major Business
    • 2.13.3 Aurobindo Pharma Finasteride API Product and Services
    • 2.13.4 Aurobindo Pharma Finasteride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Aurobindo Pharma Recent Developments/Updates

3 Competitive Environment: Finasteride API by Manufacturer

  • 3.1 Global Finasteride API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Finasteride API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Finasteride API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Finasteride API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Finasteride API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Finasteride API Manufacturer Market Share in 2024
  • 3.5 Finasteride API Market: Overall Company Footprint Analysis
    • 3.5.1 Finasteride API Market: Region Footprint
    • 3.5.2 Finasteride API Market: Company Product Type Footprint
    • 3.5.3 Finasteride API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Finasteride API Market Size by Region
    • 4.1.1 Global Finasteride API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Finasteride API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Finasteride API Average Price by Region (2020-2031)
  • 4.2 North America Finasteride API Consumption Value (2020-2031)
  • 4.3 Europe Finasteride API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Finasteride API Consumption Value (2020-2031)
  • 4.5 South America Finasteride API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Finasteride API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Finasteride API Sales Quantity by Type (2020-2031)
  • 5.2 Global Finasteride API Consumption Value by Type (2020-2031)
  • 5.3 Global Finasteride API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Finasteride API Sales Quantity by Application (2020-2031)
  • 6.2 Global Finasteride API Consumption Value by Application (2020-2031)
  • 6.3 Global Finasteride API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Finasteride API Sales Quantity by Type (2020-2031)
  • 7.2 North America Finasteride API Sales Quantity by Application (2020-2031)
  • 7.3 North America Finasteride API Market Size by Country
    • 7.3.1 North America Finasteride API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Finasteride API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Finasteride API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Finasteride API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Finasteride API Market Size by Country
    • 8.3.1 Europe Finasteride API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Finasteride API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Finasteride API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Finasteride API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Finasteride API Market Size by Region
    • 9.3.1 Asia-Pacific Finasteride API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Finasteride API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Finasteride API Sales Quantity by Type (2020-2031)
  • 10.2 South America Finasteride API Sales Quantity by Application (2020-2031)
  • 10.3 South America Finasteride API Market Size by Country
    • 10.3.1 South America Finasteride API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Finasteride API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Finasteride API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Finasteride API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Finasteride API Market Size by Country
    • 11.3.1 Middle East & Africa Finasteride API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Finasteride API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Finasteride API Market Drivers
  • 12.2 Finasteride API Market Restraints
  • 12.3 Finasteride API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Finasteride API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Finasteride API
  • 13.3 Finasteride API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Finasteride API Typical Distributors
  • 14.3 Finasteride API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Finasteride API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Finasteride API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Finasteride API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Finasteride API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Finasteride API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
    Global Finasteride API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Finasteride API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Finasteride API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AMRI, Mylan, Accord Pharmaceuticals, Sterling Spa, DEAFARMA, Gadea Grupo Farmacéutico, S.L.U., Hetero, Dr.Reddys Laboratories, Pharmaffiliates, Cipla, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Finasteride API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Abrove 99% Purity
    99% Purity
    Under 99% Purity
    Market segment by Application
    Pharmaceutical Industry
    Research Organization
    Others
    Major players covered
    AMRI
    Mylan
    Accord Pharmaceuticals
    Sterling Spa
    DEAFARMA
    Gadea Grupo Farmacéutico, S.L.U.
    Hetero
    Dr.Reddys Laboratories
    Pharmaffiliates
    Cipla
    Henan Topfond
    Khonsu International
    Aurobindo Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Finasteride API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Finasteride API, with price, sales quantity, revenue, and global market share of Finasteride API from 2020 to 2025.
    Chapter 3, the Finasteride API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Finasteride API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Finasteride API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Finasteride API.
    Chapter 14 and 15, to describe Finasteride API sales channel, distributors, customers, research findings and conclusion.

    Buy now